SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-007123
Filing Date
2016-08-02
Accepted
2016-08-02 16:16:13
Documents
53
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rigl-20160630x10q.htm 10-Q 1418449
2 EX-10.1 rigl-20160630ex101bc5433.htm EX-10.1 234680
3 EX-10.2 rigl-20160630ex10246c40c.htm EX-10.2 77752
4 EX-10.3 rigl-20160630ex103cfb3a8.htm EX-10.3 159954
5 EX-10.4 rigl-20160630ex104815e13.htm EX-10.4 166072
6 EX-31.1 rigl-20160630ex31190afc0.htm EX-31.1 19193
7 EX-31.2 rigl-20160630ex312ba35b0.htm EX-31.2 19111
8 EX-32.1 rigl-20160630ex32170c918.htm EX-32.1 11530
  Complete submission text file 0001558370-16-007123.txt   5078476

Data Files

Seq Description Document Type Size
9 EX-101.INS rigl-20160630.xml EX-101.INS 900149
10 EX-101.SCH rigl-20160630.xsd EX-101.SCH 32220
11 EX-101.CAL rigl-20160630_cal.xml EX-101.CAL 34871
12 EX-101.DEF rigl-20160630_def.xml EX-101.DEF 95666
13 EX-101.LAB rigl-20160630_lab.xml EX-101.LAB 272456
14 EX-101.PRE rigl-20160630_pre.xml EX-101.PRE 187722
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29889 | Film No.: 161800672
SIC: 2834 Pharmaceutical Preparations